Syndax Pharmaceuticals, Inc. (SNDX) short interest & options flow
NASDAQSyndax Pharmaceuticals stock jumped 9% on November 3 after reporting results that beat estimates, yet the stock remains down 19% over the past month, leaving it trading at a steep discount to analyst targets while shorts hold significant positions and options traders have abruptly shifted toward hedging. The positioning story here is a study in contrasts. Short interest has been…
SNDX short interest falls 20% in one week to 19.9% of float, yet remains elevated as cost-to-borrow stays subdued at 0.42%.
- Market cap
- $863M
- Next earnings
- 2 Mar 2027
Key data as of 12 Nov 2026
SNDX news and analysis
RSSNo long-form analysis yet for SNDX. Pulse alerts and the live data picture are available on ORTEX.
Open SNDX on ORTEX →Want the live picture for SNDX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SNDX — free to start on ORTEX.
Sign up for free →Open SNDX on ORTEX